A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo

Vaccine

Volumn 26, Issue 33, 2008, Pages 4231-4236

  Gillespie, J ^a   Juhan, N M ^a   DiCristina, J ^a   Key, K F ^a   Ramamoorthy, S ^a   Meng, X J ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

Genetic stability; Porcine circovirus type 2 (PCV2); Porcine circovirus associated disease (PCVAD); Vaccine

Indexed keywords

LIVE VACCINE; PCV1 2 CHIMERA VIRUS VACCINE; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHIMERA; CIRCOVIRIDAE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; GENE MUTATION; GENETIC ENGINEERING; GENETIC STABILITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PORCINE CIRCOVIRUS TYPE 2; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SWINE; VIREMIA; VIRUS CAPSID; VIRUS INFECTION;

AMINO ACID SUBSTITUTION; ANIMALS; CAPSID PROTEINS; CELL LINE; CIRCOVIRUS; FECES; LUNG; LYMPH NODES; MUTATION; SELECTION (GENETICS); SERIAL PASSAGE; SWINE; TONSIL; VACCINES, ATTENUATED; VIRAL VACCINES; VIRULENCE;

EID: 47349098849     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.051     Document Type: Article

References (35)

1. Allan G.M., McNeilly F., Cassidy J.P., Reilly G.A., Adair B., Ellis W.A., et al. Pathogenesis of porcine circovirus; experimental infection of colostrum deprived piglets and examination of pig foetal material. Vet Microbiol 44 (1995) 49-64
2. Allan G.M., McNeilly F., Kennedy S., Daft B., Clarke E.G., Ellis J.A., et al. Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest 10 (1998) 3-10
3. Allan G.M., McNeilly F., Meehan B.M., Kennedy S., Mackie D.P., Ellis J.A., et al. Isolation and characterization of circoviruses from pigs with wasting syndrome in Spain, Denmark, and Northern Ireland. Vet Microbiol 66 (1999) 115-123
4. Allan G.M., and Ellis J.A. Porcine circoviruses: a review. J Vet Diagn Invest 12 (2000) 3-14 [review]
5. Borges M.B., Caride E., Jabor A.V., Malachias J.N., Freire M.S., Homma A., et al. Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures. Virus Genes 36 (2008) 35-44
6. Cheung A.K. Transcriptional analysis of porcine circovirus type 2. Virology 305 (2003) 168-180
7. Cheung A.K. The essential and nonessential transcription units for viral protein synthesis and DNA replication of porcine circovirus type 2. Virology 313 (2003) 452-459
8. Chezzi C., Dommann C.J., Blackburn N.K., Maselesele E., McAnerney J., and Schoub B.D. Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells-effects of passage in cell culture and the human gastrointestinal tract. Vaccine 20 (1998) 2031-2038
9. Ellis J., Hassard L., Clark E., Harding J., Allan G., Wilson P., et al. Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J 39 (1998) 44-51
10. Ellis J., Clark E., Haines D., West K., Krakowka S., Kennedy S., and Allan G.M. Porcine circovirus-2 and concurrent infections in the field. Vet Microbiol 98 (2004) 159-163
11. Fenaux M., Halbur P.G., Gill M., Toth T.E., and Meng X.J. Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism assay to detect and differentiate between infections with PCV-1 and PCV-2. J Clin Microbiol 38 (2000) 2494-2503
12. Fenaux M., Halbur P.G., Haqshenas G., Royer R., Thomas P., Nawagitgul P., et al. The cloned genomic DNA of the type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathological lesions. J Virol 76 (2002) 541-551
13. Fenaux M., Opriessnig T., Halbur P.G., and Meng X.J. Immunogenicity and pathogenicity of the chimeric infectious DNA clones between pathogenic type 2 circovirus (PCV2) and non-pathogenic PCV1 in weaning pigs. J Virol 77 (2003) 11232-11243
14. Fenaux M., Opriessnig T., Halbur P.G., Elvinger F., and Meng X.J. A chimeric porcine circovirus (PCV) with immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 78 (2004) 6297-6303
15. Fenaux M., Opriessnig T., Halbur P.G., Elvinger F., and Meng X.J. Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo. J Virol 78 (2004) 13440-13446
16. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., and Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 26 (2008) 1063-1071
17. Harding J.C., and Clark E.G. Recognizing and diagnosing postweaning multisystemic wasting syndrome (PMWS). J Swine Health Prod 5 (1997) 201-203
18. Hesse R., Kerrigan M., and Rowland R.R. Evidence for recombination between PCV2a and PCV2b in the field. Virus Res 132 (2008) 201-207
19. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., et al. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J Am Vet Med Assoc 232 (2008) 906-912
20. Krakowka S., Ellis J., McNeilly F., Waldner C., and Allan G. Features of porcine circovirus-2 disease: correlations between lesions, amount and distribution of virus, and clinical outcome. J Vet Diagn Invest 17 (2005) 213-222
21. Lekcharoensuk P., Morozov I., Paul P.S., Thangthumniyom N., Wajjawalku W., and Meng X.J. Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J Virol 78 (2004) 8135-8145
22. Mankertz A., Mankertz J., Wolf K., and Buhk H.J. Identification of a protein essential for replication of porcine circovirus. J Gen Virol 79 (1998) 381-384
23. McKeown N.E., Opriessnig T., Thomas P., Guenette D.K., Elvinger F., Fenaux M., et al. Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2. Clin Diagn Lab Immunol 12 (2005) 1347-1351
24. Meehan B.M., Creelan J.L., McNulty M.S., and Todd D. Sequence of porcine circovirus DNA: affinities with plant circoviruses. J Gen Virol 78 (1997) 221-227
25. Meerts P., Van Gucht S., Cox E., Vandebosch A., and Nauwynck H.J. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol 18 (2005) 333-341
26. Misinzo G., Delputte P.L., Meerts P., Lefebvre D.J., and Nauwynck H.J. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J Virol 80 (2006) 3487-3494
27. Nawagitgul P., Harms P.A., Morozov I., Thacker B.J., Sorden S.D., Lekcharoensuck C., et al. Modified indirect porcine circovirus (PCV) type 2 based and recombinant capsid protein (ORF2)-based enzyme linked immunosorbent assays for detection of antibodies to PCV. Clin Diagn Lab Immunol 9 (2002) 33-40
28. Olvera A., Cortey M., and Segalés J. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology 357 (2007) 175-185
29. Opriessnig T., McKeown N.E., Zhou E.M., Meng X.J., and Halbur P.G. Genetic and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases with and without PCV2-associated lesions provides evidence for differences in virulence. J Gen Virol 87 (2006) 2923-2932
30. Opriessnig T., Meng X.J., and Halbur P.G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 19 (2007) 591-615
31. Opriessnig T., Patterson A.R., Elsener J., Meng X.J., and Halbur P.G. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2. Clin Vac Immunol 15 (2008) 397-401
32. Rosell C., Segales J., Plana-Duran J., Balasch M., Rodríguez-Arrioja G.M., Kennedy S., et al. Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs. J Comp Pathol 120 (1999) 59-78
33. Segalés J., Allan G.M., and Domingo M. Porcine circovirus diseases. Anim Health Res Rev 6 (2005) 119-142
34. Tischer I., Gelderblom H., Vettermann W., and Koch M.A. A very small porcine virus with circular single-stranded DNA. Nature 295 (1982) 64-66
35. Tischer I., Mields W., Wolff D., Vagt M., and Griem W. Studies on epidemiology and pathogenicity of procine circovirus. Arch Virol 91 (1986) 271-276